USPTO serial 79328464
FLORATEK PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 6, 2023
- Examiner
- CANTOR, JILLIAN REDDING
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with FLORATEK PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane B Melnick
Diane B Melnick Practus LLPP.O. Box 1101New York, NY 10028UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations, namely a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; medicinal preparations for the treatment of infectious diseases and for use in oncology; therapeutic preparations for treating cardiovascular diseases; pharmaceutical and medicinal preparations and substances for the treatment of diabetes; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical and medicinal preparations, substances and compositions for the treatment and/or prevention of cancer; pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders; pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases | ACTIVE | — |
| 042 | Scientific research; pharmaceutical research; medical research services in the field of medicines; technical advice for third parties in the field of development of pharmaceutical products; product development for third parties in the field of pharmaceutical products; research and development of pharmaceuticals and medicinal preparations and substances for third parties; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer; research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; research and development of pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Floratek Pharma SA
- Other trademarks owned by Floratek Pharma SA
- Other trademarks owned by Floratek Pharma SA
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named FLORATEK PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 6, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 7, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 7, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 6, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 6, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 5, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 17, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 17, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 21, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 21, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 21, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 1, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 1, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 1, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 11, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 11, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 21, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 20, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 21, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |